Recent advances in nanocarriers for nutrient delivery
© 2021. Controlled Release Society..
For the past few years, there has been a surge in the use of nutraceuticals. The global nutraceuticals market in 2020 was USD 417.66 billion, and the market value is expected to increase by 8.9% compound annual growth rate from 2020 to 2028. This is because nutraceuticals are used to treat and prevent various diseases such as cancer, skin disorders, gastrointestinal, ophthalmic, diabetes, obesity, and central nervous system-related diseases. Nutritious food provides the required amount of nutrition to the human body through diet, whereas most of the bioactive agents present in the nutrients are highly lipophilic, with low aqueous solubility leading to poor dissolution and oral bioavailability. Also, the nutraceuticals like curcumin, carotenoids, anthocyanins, omega-3 fatty acids, vitamins C, vitamin B12, and quercetin have limitations such as poor solubility, chemical instability, bitter taste, and an unpleasant odor. Additionally, the presence of gastrointestinal (GIT) membrane barriers, varied pH, and reaction with GIT enzymes cause the degradation of some of the nutraceuticals. Nanotechnology-based nutrient delivery systems can be used to improve oral bioavailability by increasing nutraceutical stability in foods and GIT, increasing nutraceutical solubility in intestinal fluids, and decreasing first-pass metabolism in the gut and liver. This article has compiled the properties and applications of various nanocarriers such as polymeric nanoparticles, micelles, liposomes, niosomes, solid lipid nanocarriers, nanostructured lipid carrier, microemulsion, nanoemulsion, dendrimers in organic nanoparticles, and nanocomposites for effective delivery of bioactive molecules.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Drug delivery and translational research - 12(2022), 10 vom: 29. Okt., Seite 2359-2384 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gorantla, Srividya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anthocyanins |
|---|
| Anmerkungen: |
Date Completed 13.09.2022 Date Revised 21.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s13346-021-01097-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333827198 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333827198 | ||
| 003 | DE-627 | ||
| 005 | 20231225222439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13346-021-01097-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1112.xml |
| 035 | |a (DE-627)NLM333827198 | ||
| 035 | |a (NLM)34845678 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gorantla, Srividya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent advances in nanocarriers for nutrient delivery |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2022 | ||
| 500 | |a Date Revised 21.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Controlled Release Society. | ||
| 520 | |a For the past few years, there has been a surge in the use of nutraceuticals. The global nutraceuticals market in 2020 was USD 417.66 billion, and the market value is expected to increase by 8.9% compound annual growth rate from 2020 to 2028. This is because nutraceuticals are used to treat and prevent various diseases such as cancer, skin disorders, gastrointestinal, ophthalmic, diabetes, obesity, and central nervous system-related diseases. Nutritious food provides the required amount of nutrition to the human body through diet, whereas most of the bioactive agents present in the nutrients are highly lipophilic, with low aqueous solubility leading to poor dissolution and oral bioavailability. Also, the nutraceuticals like curcumin, carotenoids, anthocyanins, omega-3 fatty acids, vitamins C, vitamin B12, and quercetin have limitations such as poor solubility, chemical instability, bitter taste, and an unpleasant odor. Additionally, the presence of gastrointestinal (GIT) membrane barriers, varied pH, and reaction with GIT enzymes cause the degradation of some of the nutraceuticals. Nanotechnology-based nutrient delivery systems can be used to improve oral bioavailability by increasing nutraceutical stability in foods and GIT, increasing nutraceutical solubility in intestinal fluids, and decreasing first-pass metabolism in the gut and liver. This article has compiled the properties and applications of various nanocarriers such as polymeric nanoparticles, micelles, liposomes, niosomes, solid lipid nanocarriers, nanostructured lipid carrier, microemulsion, nanoemulsion, dendrimers in organic nanoparticles, and nanocomposites for effective delivery of bioactive molecules | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Bioactive | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Curcumin | |
| 650 | 4 | |a Diseases | |
| 650 | 4 | |a Drug delivery | |
| 650 | 4 | |a Nanocarriers | |
| 650 | 4 | |a Nanoformulations | |
| 650 | 4 | |a Nanotechnology | |
| 650 | 4 | |a Nutraceuticals | |
| 650 | 4 | |a Nutrient delivery | |
| 650 | 4 | |a Solubility | |
| 650 | 4 | |a Toxicity | |
| 650 | 7 | |a Anthocyanins |2 NLM | |
| 650 | 7 | |a Lipids |2 NLM | |
| 650 | 7 | |a Liposomes |2 NLM | |
| 700 | 1 | |a Wadhwa, Geetika |e verfasserin |4 aut | |
| 700 | 1 | |a Jain, Shailja |e verfasserin |4 aut | |
| 700 | 1 | |a Sankar, Shridula |e verfasserin |4 aut | |
| 700 | 1 | |a Nuwal, Kshitij |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmood, Arisha |e verfasserin |4 aut | |
| 700 | 1 | |a Dubey, Sunil Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Taliyan, Rajeev |e verfasserin |4 aut | |
| 700 | 1 | |a Kesharwani, Prashant |e verfasserin |4 aut | |
| 700 | 1 | |a Singhvi, Gautam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug delivery and translational research |d 2011 |g 12(2022), 10 vom: 29. Okt., Seite 2359-2384 |w (DE-627)NLM207177104 |x 2190-3948 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:10 |g day:29 |g month:10 |g pages:2359-2384 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13346-021-01097-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 10 |b 29 |c 10 |h 2359-2384 | ||